OXFORD, England--(BUSINESS WIRE)--Diffblue today announced the release of the next generation of its flagship product, Diffblue Cover, to address the unmet need for automated, high quality unit test ...

Editor’s Note: This headline has been updated to reflect Jefferies’ Buy rating on Aehr Test Systems. Top Wall Street analysts changed their outlook on these top names. For a complete view of all ...

Ask almost any development team how they measure the quality of their test suite, and one answer appears almost immediately: code coverage. It appears in virtually every continuous integration ...

Cancer test maker Lucid Diagnostics (NASDAQ:LUCD), majority owned by PavMed (NASDAQ:PAVM), traded ~8% lower on Wednesday after the company said that a group of medical experts will meet in September ...

The PrecivityAD2® blood test aids health care professionals in determining the likelihood of amyloid plaques in the brain, one of the pathological hallmarks of Alzheimer's disease. As the ...

With more than 20% of organizations deploying updates multiple times per day, according to my company's study, the complexity of test authoring has grown significantly. Test authoring is the process ...

Coverage marks a pivotal step in expanding access to ultra-sensitive MRD detection for breast cancer patients U.S. Medicare coverage decision reflects published, peer-reviewed clinical data ...

Recurring 410(b) failures are rarely random. When a plan consistently struggles with coverage testing, it’s not bad luck. It’s structural. Maybe the ownership group is highly compensated and aging ...

An advisory panel to the US Food and Drug Administration handed Grail's Galleri blood test a milestone win last week, saying the early cancer detection test's potential benefits outweigh its risks and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...